Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

APVO

Aptevo Therapeutics (APVO)

Aptevo Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:APVO
일자시간출처헤드라인심볼기업
2024/06/1505:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
2024/06/1105:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
2024/06/0405:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
2024/06/0405:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
2024/06/0405:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
2024/05/0821:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
2024/05/0821:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
2024/03/0722:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
2024/03/0607:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
2024/03/0606:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
2024/03/0606:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
2024/03/0522:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:APVOAptevo Therapeutics Inc
2024/03/0522:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
2024/02/0706:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
2024/01/3108:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
2024/01/3022:00Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:APVOAptevo Therapeutics Inc
2024/01/1706:15Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:APVOAptevo Therapeutics Inc
2023/12/2306:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
2023/12/1306:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
2023/12/0114:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APVOAptevo Therapeutics Inc
2023/11/2306:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
2023/11/1007:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
2023/11/0405:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
2023/09/1605:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
2023/08/1105:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
2023/08/1105:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
2023/08/1021:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
2023/08/1021:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
2023/08/1021:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
2023/08/1021:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
 검색 관련기사 보기:NASDAQ:APVO